Vanda Pharmaceuticals Inc (VNDA)
EBITDA Growth
-87.19%
Quarterly · Period ending:
VNDA EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-87.19%period ending
Latest reported-87.19%period ending
VNDA Quarterly EBITDA YoY % (-214.07% → -87.19%)
Year-over-year change
High-resolution chart · PNG
VNDA ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -87.1946% | |
| -49.1% | |
| -610.4111% | |
| -515.7821% | |
| -826.4093% | |
| -1,134.0984% | |
| -799.4036% | |
| -1,029.7826% | |
| -211.0833% | |
| -139.3675% | |
| -104.8949% | |
| -92.5069% | |
| -28.7054% | |
| 190.3235% | |
| 10.3049% | |
| -46.2905% | |
| -66.3563% | |
| -162.0658% | |
| -19.945% | |
| 35.1064% | |
| 34.7364% | |
| 1,755.0336% | |
| 133.7686% | |
| -34.9331% | |
| -19.408% | |
| 143.3455% | |
| -49.7273% | |
| 86.2484% | |
| 162.7035% | |
| -143.748% | |
| 818.0566% | |
| 268.2574% | |
| 492.5988% | |
| 143.6407% | |
| -179.6189% | |
| -265.3647% | |
| 27.0999% | |
| 22.6672% | |
| 114.6929% | |
| 138.9536% | |
| 31.8429% | |
| -54.9842% | |
| -62.5259% | |
| -725.7692% | |
| 88.5228% | |
| 76.7885% | |
| -1.0308% | |
| 84.2265% | |
| -610.1499% | |
| -533.1132% | |
| -20.7366% | |
| -0.6309% | |
| 61.4698% | |
| 46.3174% | |
| -11.2233% | |
| -77.4007% | |
| -605.5556% | |
| -108,914.2857% | |
| -529.1311% | |
| -472.434% | |
| -166.9145% | |
| -99.8941% | |
| 114.0691% | |
| 110.2569% | |
| 113.3753% | |
| 202.726% | |
| -54.0983% | |
| 34.3729% | |
| 12.5502% | |
| 67.7291% | |
| 73.7894% | |
| 52.7178% | |
| 21.1416% | |
| -19.5618% | |
| -79.0057% | |
| -84.6448% | |
| 20.2332% | |
| 8.8357% | |
| -76.2025% | |
| -123.9639% | |
| -303.4831% | |
| -214.0741% |